More recently, high DJ-1 levels have been reported in various tumors, suggesting that abnormally expressed DJ-1 may play a role in cancer initiation and/or progression under certain circumstances [12]–[16] and may be a potential anticancer target [12]–[15]. Here, PARK7 is linked to cancer.